RxDoctor Payments Data

Christina Schmidt, NP

Nurse Practitioner · Hays, KSNPI 1750807962

Payments from drug & device makers

$645in general payments, 2019–2025

Across 34 payments — averaging $18.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$208
  • 180 Medical, Inc.$108
  • AbbVie$75
  • Urovant Sciences Inc$56
  • Sumitomo Pharma America, Inc.$55
  • Axonics, Inc.$36
  • plus $107 from 6 others

What the payments were for

  • Food & beverage$54584%
  • Education$10016%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$645 in reported general payments places this provider in the 70th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$64,746
Medicare patients
703
Services billed
1,140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron313$131,824
GemtesaVibegron138$78,249
ElmironPentosan Polysulfate Sodium14$13,716
Solifenacin Succinate267$8,775
Potassium Citrate ErPotassium Citrate49$5,185
Fesoterodine Fumarate ErFesoterodine Fumarate52$4,286
Tamsulosin Hcl425$4,127
Methenamine Hippurate50$2,785
NitrofurantoinNitrofurantoin Macrocrystal88$2,686
Finasteride218$2,264
Oxybutynin Chloride ErOxybutynin Chloride140$1,936
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst59$1,596
Testosterone Cypionate24$1,174
Oxybutynin Chloride89$1,154
Trimethoprim14$801

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$208$131,824313 claims
Sumitomo Pharma America, Inc.Gemtesa$55$78,249138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Hays

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →